Lilly drug slows Alzheimer’s by 60% for mildly impaired patients in trial
Eli Lilly’s experimental drug donanemab slowed the progression of Alzheimer’s by 60% for patients in the earliest stages of the ...
Tag: mildly
Eli Lilly’s experimental drug donanemab slowed the progression of Alzheimer’s by 60% for patients in the earliest stages of the ...